NCT03443141

Brief Summary

A prospective, randomized study will be performed. Patients are randomized using a 1:1 allocation into 2 groups: patients receiving a vitamin E-containing dressing (group 1) and a conventional dressing (group 2). The primary outcomes variable will be occurrence of incisional SSI. Follow-up will be 30 days postoperatively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2018

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2018

Completed
Last Updated

February 22, 2018

Status Verified

February 1, 2018

Enrollment Period

3 months

First QC Date

February 16, 2018

Last Update Submit

February 16, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incisional surgical site infection

    Patients present a wound with the CDC criteria for SSI

    30 days postoperatively

Study Arms (2)

Vitamin E dressing

EXPERIMENTAL

Patients will receive a Vitamin E-containing dressing over the wound

Drug: Vitamin E

Standard dressing

SHAM COMPARATOR

Patients will receive a standard dressing over the wound

Drug: Standard dressing

Interventions

The applied dressing will be embebbed in Vitamin E

Also known as: Exerimental group
Vitamin E dressing

The applied dressing is a normal one without adding any product to it.

Also known as: Control group
Standard dressing

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of colorectal neoplasms
  • plan to undergo an elective operation with curative aims
  • laparoscopic surgery

You may not qualify if:

  • Anastomotic leak
  • Lost to 30-days follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital general Universitario de Elche

Elche, Alicante, 03202, Spain

RECRUITING

MeSH Terms

Conditions

Surgical Wound Infection

Interventions

Vitamin EControl Groups

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Damian Garcia-Olmo, MD, PhD

    HOSPITAL REY JUAN CARLOS

    STUDY DIRECTOR

Central Study Contacts

Jaime Ruiz-Tovar

CONTACT

Manuel Duran, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

February 16, 2018

First Posted

February 22, 2018

Study Start

January 1, 2018

Primary Completion

March 30, 2018

Study Completion

March 30, 2018

Last Updated

February 22, 2018

Record last verified: 2018-02

Locations